.webp)
The global breast cancer core needle biopsy market size accounted for USD 1.03 billion in 2025 and is predicted to increase from USD 1.08 billion in 2026 to approximately USD 1.63 billion by 2035, expanding at a CAGR of 4.72% from 2026 to 2035. Rising screening volumes drive the breast cancer core needle biopsy pump market, preference for minimally invasive tissue sampling, and continuous improvements in imaging-guided diagnostic precision.
The global ultrasound probe disinfection market size accounted for USD 870.26 million in 2025 and is predicted to increase from USD 960.07 million in 2026 to approximately USD 2,323.76 million by 2035, expanding at a CAGR of 10.32% from 2026 to 2035. The market is fueled by the increasing adoption of infection-control protocols and mandatory reprocessing standards in healthcare facilities.
The global digital health monitoring devices market size is calculated at USD 5.36 billion in 2025 and is predicted to increase from USD 6.39 billion in 2026 to approximately USD 30.86 billion by 2035, expanding at a CAGR of 19.13% from 2026 to 2035. This market is growing due to rising adoption of remote patient monitoring technologies, driven by the increasing prevalence of chronic illnesses and the demand for real-time, data-driven healthcare.
The global gastric cancer diagnostics market size accounted for USD 1.32 billion in 2025 and is predicted to increase from USD 1.42 billion in 2026 to approximately USD 2.72 billion by 2035, expanding at a CAGR of 7.51% from 2026 to 2035. The market is driven by growing investment in oncology research and the shift toward minimally invasive diagnostic tools.
The global bioprocessing market size is calculated at USD 33.21 billion in 2025 and is predicted to increase from USD 37.90 billion in 2026 to approximately USD 124.42 billion by 2035, expanding at a CAGR of 14.12% from 2026 to 2035. The bioprocessing market is experiencing steady expansion, driven by rapid biologics production, rising demand for advanced therapies, and continuous innovation in upstream and downstream processing technologies.
The global capillary electrophoresis market size accounted for USD 648.11 million in 2025 and is predicted to increase from USD 682.07 million in 2026 to approximately USD 1,080.08 million by 2035, expanding at a CAGR of 5.24% from 2026 to 2035. The market growth is attributed to increasing demand for high-resolution, rapid, and reproducible analytical techniques in pharmaceutical, biotechnology, and clinical research applications.
The global preclinical and clinical trials market is expanding as pharmaceutical and biotech companies accelerate drug development and invest in advanced testing solutions. The market is expanding rapidly due to the impending threat of antibiotic-resistant pathogens, a rapid shift towards outsourcing, the active presence of biotechnology and pharmaceutical companies for R&D to develop new drugs, and supportive government regulations.
The global coagulation analyzers market size accounted for USD 5.07 billion in 2025 and is predicted to increase from USD 5.34 billion in 2026 to approximately USD 8.52 billion by 2035, expanding at a CAGR of 5.33% from 2026 to 2035. The coagulation analyzers market is poised for significant growth, with projections indicating a robust increase.
The global thoracic outlet syndrome market size is calculated at USD 234.18 million in 2025 and is predicted to increase from USD 248.02 million in 2026 to approximately USD 415.83 million by 2035, expanding at a CAGR of 5.91% from 2026 to 2035. The thoracic outlet syndrome market is driven by growing diagnostic awareness, improved minimally invasive treatments, and rising prevalence of musculoskeletal disorders.
The global life science research services market size is calculated at USD 35.37 billion in 2025 and is predicted to increase from USD 39.09 billion in 2026 to approximately USD 96.26 billion by 2035, expanding at a CAGR of 10.53% from 2026 to 2035. The life science research services market is witnessing unprecedented growth, driven by the rapid expansion of biotech startups and a surge in R&D spending.
The canada womens health market size is calculated at USD 1.97 billion in 2025 and is predicted to increase from USD 2.08 billion in 2026 to approximately USD 3.38 billion by 2035, expanding at a CAGR of 5.52% from 2026 to 2035. The market is experiencing rapid growth to bridge the gap between women's deteriorating health and its adverse effects on the country’s GDP, to increase awareness of proactive healthcare solutions, and to grow the FemTech domain in Canada.
The global life science imaging market is a rapidly growing sector driven by advanced imaging technologies, rising R&D in biotech and pharmaceuticals, and the increasing need for high-resolution biological imaging solutions. Rising cyber threats and the shift toward passwordless and multi-factor authentication across enterprises drive market growth.
The global pharmaceutical quality management software market size is calculated at USD 2.35 billion in 2025 and is predicted to increase from USD 2.66 billion in 2026 to approximately USD 8.03 billion by 2034, expanding at a CAGR of 13.07% from 2026 to 2035. The market is witnessing market expansion is primarily driven by rising research & development investments, increasing healthcare demands from an aging population, pressure to meet stringent regulatory standards, and the incorporation of advanced technologies like AI, ML, and robotics.
The global preparative and process chromatography market size accounted for USD 14.07 billion in 2025 and is predicted to increase from USD 14.87 billion in 2026 to approximately USD 24.54 billion by 2035, expanding at a CAGR of 5.72% from 2026 to 2035. This market is growing due to increasing demand for high-purity biologics and pharmaceuticals, coupled with advancements in separation technologies.
The global uterine fibroid drugs market size is calculated at USD 3.16 billion in 2025 and is predicted to increase from USD 3.61 billion in 2026 to approximately USD 11.93 billion by 2035, expanding at a CAGR of 14.21% from 2026 to 2035. This market is growing due to the increasing prevalence of fibroids among women of reproductive age and the rising demand for non-surgical, effective treatment options.
The global lentivirus manufacturing for advanced therapies market is growing as demand rises for viral vectors used in gene therapy, cell therapy, and cutting-edge regenerative treatments. The expansion of gene therapy pipelines primarily drives the lentivirus manufacturing for advanced therapies market.
Omics technologies refer to a set of advanced scientific methods used to analyze and interpret large-scale biological data across various domains, such as genomics, proteomics, metabolomics, and transcriptomics. These technologies enable researchers to study the entire set of genes (genomics), proteins (proteomics), metabolites (metabolomics), or RNA molecules (transcriptomics) in a biological sample, providing comprehensive insights into cellular processes, disease mechanisms, and the development of personalized medicine.
The global unified communications as a service in healthcare market size is calculated at USD 10.37 billion in 2025 and is predicted to increase from USD 11.43 billion in 2026 to approximately USD 27.44 billion by 2035, expanding at a CAGR of 10.22% from 2026 to 2035. The market is driven by rising demand for secure, real-time communication and enhanced telehealth efficiency in healthcare.
The global life science data management market is growing as organizations adopt advanced platforms to handle complex research data, improve workflows, and ensure compliance. This market is growing due to rising volumes of complex biological data requiring efficient and secure management.
The global pharmaceutical and biotechnology analytics market is growing as companies adopt advanced data tools to improve drug development, R&D efficiency, and decision-making. The market is witnessing substantial growth due to the rising R&D Investments, increased healthcare demands from an aging population, and the pressure to meet stringent regulatory standards. Furthermore, the incorporation of advanced technologies like AI, ML, and robotics is transforming the market, enabling better data interpretation with improved efficiency, accuracy, and data management.
The cGMP manufacturing market is the heart of the current biopharmaceutical manufacturing, which guarantees that drugs, biologics, cell and gene therapies, and vaccines are manufactured to global standards of quality, safety, and consistency. The market is at the interfaces of a broad spectrum, both upstream and downstream processing, as well as formulation, aseptic filling, analytical testing, and regulatory documentation. With the increasingly complex therapeutic pipelines and tightened controls of regulatory authorities, the presence of cGMP-certified facilities and technologies is becoming a necessity.
The global life science big data market is expanding rapidly as healthcare, genomics, and biotech sectors adopt advanced analytics to accelerate research and innovation. This market is growing due to rising demand for real-time analytics that accelerate drug discovery, personalized medicine, and clinical decision-making.
The global clinical data management market size is calculated at USD 3.62 billion in 2025 and is predicted to increase from USD 4.04 billion in 2026 to approximately USD 10.89 billion by 2035, expanding at a CAGR of 11.64% from 2026 to 2035. This market is growing as digital platforms are increasingly adopted to streamline data collection, analysis, and regulatory compliance in clinical trials.
The global intraocular lens market size is calculated at USD 5.10 billion in 2025 and is predicted to increase from USD 5.34 billion in 2026 to approximately USD 8.09 billion by 2035, expanding at a CAGR of 4.72% from 2026 to 2035. The intraocular lens market is witnessing unprecedented growth, driven by rising cataract surgery incidence.
The global next generation vector engineering market is expanding rapidly as advances in gene therapy and synthetic biology drive demand for innovative vector design solutions. Market growth is driven by the rising prevalence of genetic disorders and the increasing adoption of viral and non-viral vector-based gene therapies for targeted, personalized treatments.
The global specimen collection cards market size accounted for USD 502.11 million in 2025 and is predicted to increase from USD 528.82 million in 2026 to approximately USD 843.15 million by 2035, expanding at a CAGR of 5.32% from 2026 to 2035. The market is driven by the expansion of modern healthcare infrastructure, the increasing prevalence of infectious diseases worldwide, the growing need for newborn screening, and ongoing technological advancements in specimen collection cards.
The global life science laboratory automation market is expanding due to rising demand for high-throughput testing, precision workflows, and reduced manual errors. The life science laboratory automation market is driven by rising demand for high-throughput workflows, AI-enabled lab systems, expanding biopharma research, and the shift toward precision, error-free, and scalable laboratory operations.
The global articaine hydrochloride market size accounted for USD 1.64 billion in 2025 and is predicted to increase from USD 1.74 billion in 2026 to approximately USD 2.94 billion by 2035, expanding at a CAGR of 6.02% from 2026 to 2035. The market is experiencing robust growth driven by the increasing prevalence of dental issues, growing awareness of preventive healthcare measures, the significance of articaine anesthesia in dental procedures, and government reimbursement for oral care/ procedures, which are assisting the markets global expansion.
The global radiology AI market size accounted for USD 794.12 million in 2025 and is predicted to increase from USD 989.55 million in 2026 to approximately USD 7,168.28 million by 2035, expanding at a CAGR of 24.61% from 2026 to 2035. The market for radiology AI is experiencing unprecedented growth, driven by the increasing demand for early detection of chronic diseases.
The global diagnostic tools market size accounted for USD 46.11 billion in 2025 and is predicted to increase from USD 48.13 billion in 2026 to approximately USD 67.76 billion by 2034, expanding at a CAGR of 4.37% from 2025 to 2034. This market is growing due to rising demand for early, accurate, and rapid disease detection, driven by the rise in chronic illnesses and advancements in healthcare technologies.
The global life science consumables market size is calculated at USD 31.88 billion in 2025 and is predicted to increase from USD 33.64 billion in 2026 to approximately USD 51.70 billion by 2034, expanding at a CAGR of 5.52% from 2025 to 2034. The market is expanding significantly owing to advancements in life science consumables enabled by cutting-edge technologies, laboratory automation, increased R&D to curb the growing incidence of chronic diseases, and strong government support for developing the healthcare sector.
The global follicular lymphoma market size is calculated at USD 1.90 billion in 2025 and is predicted to increase from USD 1.97 billion in 2026 to approximately USD 2.65 billion by 2034, expanding at a CAGR of 3.76% from 2025 to 2034. The follicular lymphoma market is witnessing unprecedented growth, driven by the rising prevalence of follicular lymphoma as a common type of non-Hodgkin lymphoma, which is expanding the patient pool requiring treatment.
The global laboratory centrifuges market size accounted for USD 2.06 billion in 2025 and is predicted to increase from USD 2.18 billion in 2026 to approximately USD 3.51 billion by 2034, expanding at a CAGR of 6.11% from 2025 to 2034. The market for laboratory centrifuges is driven by increasing demand for advanced sample preparation in clinical diagnostics and biotechnology research.
The global life science cloud computing market grows as pharma and biotech adopt cloud platforms to accelerate R&D, improve data management, and enhance collaboration. The market for life science cloud computing is driven by rising digitalization, growing R&D data volumes, and increasing adoption of advanced analytics and collaborative cloud platforms across biotech and healthcare.
The global dementia treatment market size accounted for USD 19.98 billion in 2025 and is predicted to increase from USD 21.62 billion in 2026 to approximately USD 40.64 billion by 2034, expanding at a CAGR of 8.21% from 2025 to 2034. The market for dementia treatment is driven by rising healthcare expenditure, a surge in the prevalence of dementia, a rising geriatric population, increasing R&D activities, and the increasing introduction of new therapeutic products.
The global pharmaceutical inspection machines market size accounted for USD 1.18 billion in 2025 and is predicted to increase from USD 1.30 billion in 2026 to approximately USD 2.81 billion by 2034, expanding at a CAGR of 10.15% from 2025 to 2034. This market is growing as demand for automated quality control increases to ensure product safety, accuracy, and compliance with strict regulatory standards.
The global EMEA 3D CBCT market size accounted for USD 667.87 million in 2025 and is predicted to increase from USD 727.57 million in 2026 to approximately USD 1,443.37 million by 2034, expanding at a CAGR of 8.94% from 2025 to 2034. The increasing prevalence of dental diseases, the growing geriatric population, the importance of aesthetics with rising disposable income, and government-backed programs supporting dental tourism and major investments in advanced healthcare infrastructure are major drivers of the markets dominance.
The global MRI safe implantable defibrillator devices market size accounted for USD 1,750 million in 2025 and is predicted to increase from USD 1,890 million in 2026 to approximately USD 3,400 million by 2034, expanding at a CAGR of 7.64% from 2025 to 2034. The market for MRI safe implantable defibrillator devices is driven by rising cardiac disorders, increasing MRI procedures, and technological advancements in safer, more efficient implantable devices.
The global genAI mental health devices market is evolving rapidly as AI-powered wearables, sensors, and diagnostic tools enhance emotional wellbeing, early detection, and personalized mental health support. The GenAI mental health devices market is driven by rising demand for personalized support, improved diagnostic capabilities, and broader integration of AI-powered therapeutic tools across diverse healthcare settings.
The global epigenetic drugs market size is calculated at USD 16.22 billion in 2025 and is predicted to increase from USD 19.39 billion in 2026 to approximately USD 80.81 billion by 2034, expanding at a CAGR of 19.53% from 2025 to 2034. The epigenetic drugs market is experiencing steady growth, driven by advancements in oncology research, rising adoption of precision medicine, and an increase in clinical trials targeting epigenetic mechanisms.
The global single nucleotide polymorphism (SNP) genotyping market size accounted for USD 7.52 billion in 2025 and is predicted to increase from USD 9.11 billion in 2026 to approximately USD 42.12 billion by 2034, expanding at a CAGR of 21.10% from 2025 to 2034. The market is rapidly expanding due to advancements in genomic technology, the rise in fatal and chronic diseases, the expansion of SNP genotyping applications, and substantial government funding for R&D in the pharma and biotech sectors worldwide.
The global bromelain market size is calculated at USD 34.38 billion in 2025 and is predicted to increase from USD 36.74 billion in 2026 to approximately USD 62.42 billion by 2034, expanding at a CAGR of 6.85% from 2025 to 2034. The bromelain market is driven by rising demand in pharmaceuticals, food processing, and cosmetics due to its natural enzymatic and anti-inflammatory properties.
The global photothermal therapy patches market size is calculated at USD 275.29 million in 2025 and is predicted to increase from USD 295.83 million in 2026 to approximately USD 526.03 million by 2034, expanding at a CAGR of 7.46% from 2025 to 2034. The increasing elderly population, the burden of chronic disease, and governments need to invest heavily in robust healthcare services amid growing demand for non-invasive, yet effective and personalized treatment are propelling the photothermal therapy patches market globally.
The global extracellular vesicles-based liquid biopsy market size is calculated at USD 122.72 million in 2025 and is predicted to increase from USD 125.45 million in 2026 to approximately USD 149.66 million by 2034, expanding at a CAGR of 2.23% from 2025 to 2034. This market is growing due to the increasing demand for minimally invasive diagnostic tools and the rising global prevalence of cancer.
The global extended migraine prophylactics market size is calculated at USD 4.06 billion in 2025 and is predicted to increase from USD 4.56 billion in 2026 to approximately USD 11.66 billion by 2034, expanding at a CAGR of 12.44% from 2025 to 2034. This market is growing due to the rising prevalence of chronic migraines and increasing adoption of long-acting preventive therapies that offer improved patient compliance and sustained symptom relief.
The global bioinformatics services market size is calculated at USD 3.94 billion in 2025 and is predicted to increase from USD 4.52 billion in 2026 to approximately USD 13.66 billion by 2034, expanding at a CAGR of 14.82% from 2025 to 2034. The bioinformatics services market is driven by increased funding and investment, growing adoption of cloud-based solutions, and the integration of artificial intelligence and machine learning for biological data processing and analysis.
The global contract pharmaceutical fermentation services market size accounted for USD 16.16 billion in 2025 and is predicted to increase from USD 17.46 billion in 2026 to approximately USD 32.39 billion by 2034, expanding at a CAGR of 8.03% from 2025 to 2034. The market is driven by increasing demand for biologics, rising outsourcing among pharma companies, and advancements in microbial and cell-culture fermentation technologies.
The global nasal polyposis treatment market size accounted for USD 5.27 billion in 2025 and is predicted to increase from USD 5.61 billion in 2026 to approximately USD 9.15 billion by 2034, expanding at a CAGR of 6.32% from 2025 to 2034. This market is growing due to the rising prevalence of chronic rhinosinusitis and the increasing adoption of biologic therapies for effective term management.
The global patient experience technology market size is calculated at USD 691.96 million in 2025 and is predicted to increase from USD 774.51 million in 2026 to approximately USD 1,908.10 million by 2034, expanding at a CAGR of 11.93% from 2025 to 2034. This market is growing due to rising demand for personalized, seamless, and digitally integrated healthcare solutions that enhance patient engagement and satisfaction.
The global cellulose-reinforced hydrogels market size accounted for USD 1.44 billion in 2025 and is predicted to increase from USD 1.54 billion in 2026 to approximately USD 2.62 billion by 2034, expanding at a CAGR of 6.85% from 2025 to 2034. The market is driven by the growing demand for sustainable biomaterials, advancements in tissue engineering, and increasing applications in drug delivery and wound healing.
